Adarsh Bhimraj

9PUBLICATIONS
26CO-AUTHORS
Infectious diseasesGene and molecular therapyClinical pharmacology and therapeuticsCardiology (incl. cardiovascular diseases)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
State-of-the-Art Review: Infections in Patients With Cerebrospinal Fluid Shunts.

|Apr 01, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

Amy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo

|Apr 01, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Sep 09, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Aug 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Aug 04, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.

Adarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden

Pageof 2

Frequent Collaborators

6 joint publications

Laura Riley

6 joint publications

Shmuel Shoham

6 joint publications

Pablo Tebas

6 joint publications

Roger Bedimo